Atlas Bio
Atlas Bio develops AI models that simulate patient responses to help biopharma teams assess drug development decisions.
$2.5MPreviously undisclosed pre-seed
LeadFM
First Momentum Ventures
Activity from announced rounds
Activity in this selectionOct 28, 2026 · Europe · Jan 1, 2026
- Rounds participated in
- 4
- Confirmed lead rounds
- 1 1 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $34.5M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionTURN2X
Modular plants that convert renewable electricity into synthetic methane.
€20MSeries A
ParticipantZuriQ
ZuriQ develops trapped-ion quantum processors using a native two-dimensional architecture.
$25.5MSeed
ParticipantISPTech
Develops propulsion systems for in-orbit manoeuvring
€5.5MSeed
Role not disclosed